DAC for study: "Circulating tumour DNA abundance and potential utility in de novo metastatic prostate cancer"

Alexander Wyatt
awyatt@prostatecentre.com

Request Access

Dataset ID	Description	Technology	Samples
EGAD00001004526	We set out to determine ctDNA abundance at de novo mCSPC diagnosis and whether ctDNA provides complementary clinically relevant information to a prostate biopsy. We collected and sequenced 77 plasma cell-free DNA samples from 53 newly diagnosed patients with mCSPC. Targeted sequencing was also performed on DNA from 48 diagnostic prostate tissue samples.	Illumina HiSeq 2500	178